NCT03501602

Brief Summary

Investigators aimed to compare the ease of use of the LMA protector and I-gel LMA for tracheal intubation with the Aintree catheter in our study. Laryngeal mask airway (LMA) protector is the second generation perilaryngeal seal type supraglottic airway tool. The I-gel LMA is the second generation uncuffed supraglottic airway device. The Aintree Intubation Catheter has been designed for assisted fiberoptic intubation and for uncomplicated, atraumatic endotracheal tube exchange.Both LMA types have a structure that permits endotracheal intubation. In cases of difficult intubation, these two LMA types can be used. In the literature, there is no study comparing these two LMA types using Aintree catheter.Difficult Airway Society (DAS) published a guide for tracheal intubation in 2011 using Aintree. According to this guide, LMA type LMA Supreme is the most unfavorable for this process. However, there is no research or recommendation on the type of LMA most suitable for use in the literature. In accordance with the data of this study, it will be tried to show which LMA type may be suitable for intubation with Aintree catheter in patients.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
80

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Apr 2018

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 5, 2018

Completed
5 days until next milestone

First Submitted

Initial submission to the registry

April 10, 2018

Completed
8 days until next milestone

First Posted

Study publicly available on registry

April 18, 2018

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 5, 2019

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

July 5, 2019

Completed
Last Updated

April 19, 2018

Status Verified

April 1, 2018

Enrollment Period

1 year

First QC Date

April 10, 2018

Last Update Submit

April 17, 2018

Conditions

Keywords

aintree, LMA protector; I-gel LMA, Fiberoptic Bronchoscope

Outcome Measures

Primary Outcomes (1)

  • Time to Successful Tracheal Intubation

    This measure of time begins with the handling of the supraglottic device to confirming the appropriate placement of the device by noting the presences of end tidal carbon dioxide.

    Up to 10 minutes

Secondary Outcomes (3)

  • Time to Placement of the Supra Glottic Device

    Up to 10 minutes

  • Time to Placement of the Aintree Airway Intubation Catheter

    Up to 10 minutes

  • Laryngeal appearance staging

    Up to 10 minutes

Other Outcomes (13)

  • Mouth openness

    Up to 10 minutes

  • thiromental distance

    Up to 10 minutes

  • pre-induction systolic and diastolic pulse

    Up to 10 minutes

  • +10 more other outcomes

Study Arms (2)

LMA protector group

ACTIVE COMPARATOR

The LMA Protector is a single use supraglottic airway device. This airway device provides access and functional separation of the respiratory and digestive tracts

Device: LMA protector

I-gel LMA group

ACTIVE COMPARATOR

The I-gel is an alternative supraglottic device which provides the seal over the airway versus an inflatable cuff.

Device: I-gel LMA

Interventions

In this arm the LMA protector will be inserted. The time from took the LMA to placement of the LMA will be recorded. In patients with adequate ventilation, an Aintree catheter placed on a fiberoptic bronchoscope in LMA will be delivered. Cord vocals will be seen on the monitor and the aintree catheter will be sent into the trachea. After the insertion of the trachea, the fiberoptic bronchoscope and LMA are removed and the patient's intubation tube is advanced through the Aintree catheter to the patient's trachea. Once you have made sure that the tube is in the trachea, it will be removed. The time from insertion of the LMA to placement of the endotracheal tube will be recorded.

Also known as: aintree catheter, Fiberoptic brochoscop
LMA protector group
I-gel LMADEVICE

In this arm the I-gel LMA will be inserted. The time from took the LMA to placement of the LMA will be recorded. In patients with adequate ventilation, an Aintree catheter placed on a fiberoptic bronchoscope in LMA will be delivered. Cord vocals will be seen on the monitor and the aintree catheter will be sent into the trachea. After the insertion of the trachea, the fiberoptic bronchoscope and LMA are removed and the patient's intubation tube is advanced through the Aintree catheter to the patient's trachea. Once you have made sure that the tube is in the trachea, it will be removed. The time from insertion of the LMA to placement of the endotracheal tube will be recorded.

Also known as: aintree catheter, Fiberoptic brochoscop
I-gel LMA group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Be intubated in surgical operation requiring intubation
  • over 18 years old

You may not qualify if:

  • Difficult intubation story
  • Difficult intubation risk
  • Presence of gastric reflux

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Aslı Duygu Aydaş

Kocaeli, Derince, 41900, Turkey (Türkiye)

RECRUITING

Study Officials

  • Kemal T Saraçoğlu, assoc. prof.

    Sağlık Bilimleri Üniversitesi Kocaeli Derince Eğitim ve Araştırma Hastanesi

    STUDY CHAIR

Central Study Contacts

Aslı D Aydaş, Doctor

CONTACT

Kemal T Saraçoğlu, assoc. prof.

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
OTHER
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
specialist doctor

Study Record Dates

First Submitted

April 10, 2018

First Posted

April 18, 2018

Study Start

April 5, 2018

Primary Completion

April 5, 2019

Study Completion

July 5, 2019

Last Updated

April 19, 2018

Record last verified: 2018-04

Locations